niftify.in

niftify.in

Latest Pfizer News

Stay Informed on Pfizer Stock News: Access the latest Pfizer stock news, industry updates, and quick information on Pfizer stock buybacks,Pfizer results, Pfizer company analysis, Pfizer live prices, Pfizer dividends, Pfizer bonus share, board meetings, lifetime highs, Pfizer targets, lows, and growth stories with AI—all in one place.

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, urging the company to improve its performance. Starboard has reached out to former execs for assistance, while Pfizer faces challenges with falling COVID-19 sales and competition for its drugs.
Mint

Mint

Pfizer faces pressure as activist investor Starboard Value takes $1 billion stake

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, urging the company to improve its performance. Starboard has reached out to former execs for assistance, while Pfizer faces challenges with falling COVID-19 sales and competition for its drugs.

Mon, Oct 7, 2024

The centre is expected to accelerate data science and AI solutions to meet Pfizer’s ambitions in modernising marketing and creating an agile sales force
Business Line

Business Line

Pfizer launches ‘Analytics Gateway’ in India, its first dedicated global commercial analytics centre

The centre is expected to accelerate data science and AI solutions to meet Pfizer’s ambitions in modernising marketing and creating an agile sales force

Wed, Sep 18, 2024

Pfizer has launched its first dedicated commercial analytics centre in Mumbai, named 'the Analytics Gateway'. This centre will support Pfizer's international markets by providing data and analytics insights to benefit patients. It aims to modernize marketing, create an agile sales force, and enhance commercial effectiveness globally.
The Economic Times

The Economic Times

Pfizer sets up analytics capability centre in Mumbai

Pfizer has launched its first dedicated commercial analytics centre in Mumbai, named 'the Analytics Gateway'. This centre will support Pfizer's international markets by providing data and analytics insights to benefit patients. It aims to modernize marketing, create an agile sales force, and enhance commercial effectiveness globally.

Wed, Sep 18, 2024

Pfizer’s experimental cancer weight loss drug helped patients regain weight in a mid-stage study giving fresh promise for the dangerous muscle-wasting condition
Hindustan Times

Hindustan Times

Pfizer drug helped cancer patients regain lost weight, study shows

Pfizer’s experimental cancer weight loss drug helped patients regain weight in a mid-stage study giving fresh promise for the dangerous muscle-wasting condition

Sun, Sep 15, 2024

On Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $107.5 million award against AstraZeneca. Pfizer had claimed AstraZeneca's Tagrisso infringed these patents. Judge Kennelly's ruling found the patents lacked sufficient written descriptions and were not reproducible by a skilled scientist. This decision dismisses the damages awarded in May and affects Pfizer’s ongoing patent infringement claims. The case, Wyeth LLC v. AstraZeneca Pharmaceuticals LP, was heard in the District of Delaware.
The Economic Times

The Economic Times

AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fight

On Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $107.5 million award against AstraZeneca. Pfizer had claimed AstraZeneca's Tagrisso infringed these patents. Judge Kennelly's ruling found the patents lacked sufficient written descriptions and were not reproducible by a skilled scientist. This decision dismisses the damages awarded in May and affects Pfizer’s ongoing patent infringement claims. The case, Wyeth LLC v. AstraZeneca Pharmaceuticals LP, was heard in the District of Delaware.

Wed, Aug 14, 2024